How pharmacy application will help you to grow your pharma business while all other industries are facing big loss due to Corona virus disease?
AS THE NEW CORONAVIRUS spreads death, illness, and catastrophe around the globe, virtually no economic sector has been saved from harm. However amid the disorder from the worldwide pandemic, one industry isn’t just surviving, it is benefitting liberally.
“Pharmaceutical organizations view Covid-19 as a once-in-a-blue-moon business opportunity,” said Gerald Posner, author of “Pharma: Greed, Lies, and the Poisoning of America.” The world needs pharmaceutical products, obviously. For the new coronavirus outbreak, specifically, we need vaccines and treatments and, in the U.S., tests. Many organizations are presently vying to make them.
“They’re all in that race,” said Posner, who described the potential payoffs for winning the race as tremendous. The worldwide emergency “will possibly be a blockbuster for the industry in terms of profits and sales,” he said, including that “the more awful the pandemic gets, the higher their inevitable profit.”
During the present crisis, pharmaceutical makers may have considerably more leeway than expected because of language industry lobbyists embedded into an $8.3 billion coronavirus spending package, passed last week, to amplify their profits from the pandemic.
Notwithstanding shares of Piramal Enterprises that fell around 0.3%, all the 9 other healthcare shares were trading more on Nifty Pharma, which was high around 0.78% at 8,200.
On Nifty Pharma, Cadila Healthcare was the highest gainer, rising 4.7%, trailed by 2% gain in Divi's Laboratories. Biocon increased by 1.68%, while Sun Pharma and Dr Reddy's were up 1%. Cipla Glenmark, and Aurobindo Pharma, Pharmaceuticals gained in the range of 0.2% to 0.8%.
Shares of Biocon, Dr Reddy's Labs, and Divi's Laboratories were moving towards their 52-week highs on NSE today.
Nifty Pharma index has gained 3.68% in one week, 2.7% in one month and 1.68% since the beginning of 2020.
On a similar note, BSE Healthcare traded at 14,194, rising 0.81%, with 20 of 30 scrips trading in the green. On the BSE sector list, Shilpa Medicare and IOL Chemical rose around 5% each, followed by 4-5% high in Marksans Pharma, Panacea Biotec, and Cadila. Albert David, Laurus Labs, and Granules India gained around 3% each.
BSE Healthcare index has gained 1.87% in one week, 1.80% in one month and 5.72% since the beginning of 2020.
The rise in the share price of healthcare stocks is on the back of the global trend. The spread of the novel coronavirus has driven worldwide investors to scramble for pharmaceutical stocks s of late, on back of a rise in demand for branded generics and generics prompting to over-pricing and shortages for medicines. All around, the number has moved to more than 95,000 affected and more than 3,200 fatalities.
How Online Pharma Application is Helping Pharma companies to deliver medicines quickly
- Allowing consumers to be more accessible to the medicines
- Consumers can easily order their prescribed medicines through mobile app and get them delivered right to their door
- Educating and informing people about their health and safety concerns in the corona situation
- Through advanced technology used in the mobile app, pharmacies can ensure that your medicine orders are filled correctly and you get the right medicine
- They can handle a larger number of medicine orders and deliver medicines with a higher efficiency rate
- With a customized mobile healthcare solution, pharma companies can focus more on patient’s clinical needs instead of counting pills
- Enable remote monitoring by health professionals of a patient's condition and adherence to treatment
If you’re a pharma company having an existing online medicine delivery app or want to develop an advanced medicine delivery app that can help consumers in such crises as coronavirus and increase your brand name as well as revenue, feel free to contact EMedStore – A leading pharma solution provider.
Be safe, and maintain hygiene!